Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analysis of Circulating Long Non-Coding RNA in Prediabetes or Newly Diagnosed Type 2 Diabetes Subjects With or Without Heart Stress.

Diabetes/metabolism research and reviews·2026
Same authorSame journal

Exercise Training and Cardiac Rehabilitation in Chronic Thromboembolic Pulmonary Hypertension.

Heart failure clinics·2026
Same author

Hospital-to-community care pathways for patients with heart failure, an inter-society consensus document.

European journal of internal medicine·2026
Same author

Cardiac rehabilitation in overweight and obese patients: Challenges, strategies, and the role of emerging anti-obesity therapies.

Current problems in cardiology·2026
Same author

Prognostic Thresholds of Pulmonary Artery Pressure and Right Ventricular Function at Echocardiography in Heart Failure.

The American journal of cardiology·2026
Same author

Integrating Host Genetics and Clinical Setting in Machine Learning Models: Predicting COVID-19 Prognosis for Healthcare Decision-Making (The FeMiNa Study).

Diagnostics (Basel, Switzerland)·2026

Related Experiment Video

Updated: May 12, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

Takotsubo cardiomyopathy: overview.

Eduardo Bossone1, Gianluigi Savarese, Francesco Ferrara

  • 1Department of Cardiac Surgery, IRCCS Policlinico San Donato, Piazza Edmondo Malan 1, 20097 San Donato Milanese, Italy.

Heart Failure Clinics
|April 9, 2013
PubMed
Summary
This summary is machine-generated.

Takotsubo cardiomyopathy (TTC) is a heart condition causing temporary left ventricular dysfunction, often triggered by stress in postmenopausal women. Early suspicion and imaging are key for diagnosis, with angiography essential to rule out heart attacks.

More Related Videos

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

Related Experiment Videos

Last Updated: May 12, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

Area of Science:

  • Cardiology
  • Internal Medicine

Background:

  • Takotsubo cardiomyopathy (TTC) presents as acute left ventricular systolic dysfunction.
  • It occurs without significant coronary artery disease, predominantly in postmenopausal women following stress.
  • Nonspecific symptoms necessitate a high clinical suspicion for accurate diagnosis.

Purpose of the Study:

  • To review the clinical features of Takotsubo cardiomyopathy.
  • To discuss current management strategies for TTC.
  • To provide new insights into the understanding and treatment of TTC.

Main Methods:

  • Review of clinical features, diagnostic modalities, and management of TTC.
  • Emphasis on noninvasive multimodality imaging for differential diagnosis.
  • Coronary angiography as a mandatory tool to distinguish TTC from acute coronary syndromes.

Main Results:

  • TTC is characterized by transient systolic dysfunction mimicking acute coronary syndromes.
  • Noninvasive imaging aids in differentiating TTC from other cardiac and thoracic conditions.
  • Coronary angiography is crucial for definitive diagnosis by excluding obstructive coronary artery disease.

Conclusions:

  • Takotsubo cardiomyopathy requires a high index of clinical suspicion due to its varied presentations.
  • Multimodality imaging plays a vital role in the diagnostic workup.
  • Coronary angiography remains indispensable for differentiating TTC from acute coronary syndromes, guiding appropriate patient management.